- FDA clears PGD as the first rapid test for bacteria in pooled platelets
- Verax to Present Whole Blood Derived Platelet testing data at AABB annual meeting in New Orleans
- Verax Biomedical enters exclusive worldwide distribution agreement with Fenwal Incorporated
- Verax Biomedical Platelet PGD® Test for Bacterial Detection Now CE Marked
- Verax Biomedical Receives ISO Certification
- Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
- Verax to present 7 abstracts at AABB annual meeting in Anaheim, October 20-23rd
- Verax Biomedical to Present at Annual ISBT Symposium
Verax Biomedical
Skip to contentVerax Biomedical is the leading developer of rapid tests for the detection of bacterial contaminants in blood components, tissues for transplantation and cellular therapies. These tests are based upon our proprietary Pan Genera® Detection (PGD®) technology which permits the rapid detection of a broad array of bacteria in a simple, easy to use test format.
